These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant. Porotto M, Greengard O, Poltoratskaia N, Horga MA, Moscona A. J Virol; 2001 Aug; 75(16):7481-8. PubMed ID: 11462020 [Abstract] [Full Text] [Related]
4. Analysis of human parainfluenza virus 3 receptor binding variants: evidence for the use of a specific sialic acid-containing receptor. Moscona A, Peluso RW. Microb Pathog; 1996 Mar; 20(3):179-84. PubMed ID: 8965678 [Abstract] [Full Text] [Related]
5. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle. Huberman K, Peluso RW, Moscona A. Virology; 1995 Dec 01; 214(1):294-300. PubMed ID: 8525632 [Abstract] [Full Text] [Related]
9. Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo. Prince GA, Ottolini MG, Moscona A. J Virol; 2001 Dec 01; 75(24):12446-51. PubMed ID: 11711635 [Abstract] [Full Text] [Related]
10. Interaction between the hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. Xu R, Palmer SG, Porotto M, Palermo LM, Niewiesk S, Wilson IA, Moscona A. mBio; 2013 Oct 22; 4(5):e00803-13. PubMed ID: 24149514 [Abstract] [Full Text] [Related]
11. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. J Virol; 2005 Feb 22; 79(4):2383-92. PubMed ID: 15681439 [Abstract] [Full Text] [Related]
12. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA. Greengard O, Poltoratskaia N, Leikina E, Zimmerberg J, Moscona A. J Virol; 2000 Dec 22; 74(23):11108-14. PubMed ID: 11070006 [Abstract] [Full Text] [Related]
17. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites. Porotto M, Murrell M, Greengard O, Lawrence MC, McKimm-Breschkin JL, Moscona A. J Virol; 2004 Dec 22; 78(24):13911-9. PubMed ID: 15564499 [Abstract] [Full Text] [Related]
18. Human parainfluenza virus 3 neuraminidase activity contributes to dendritic cell maturation. Horga MA, Macip S, Tuyama AC, Tan MC, Gusella GL. Viral Immunol; 2005 Dec 22; 18(3):523-33. PubMed ID: 16212531 [Abstract] [Full Text] [Related]
19. A cell fusion-inhibiting monoclonal antibody binds to the presumed stalk domain of the human parainfluenza type 2 virus hemagglutinin-neuraminidase protein. Yuasa T, Kawano M, Tabata N, Nishio M, Kusagawa S, Komada H, Matsumura H, Ito Y, Tsurudome M. Virology; 1995 Feb 01; 206(2):1117-25. PubMed ID: 7531915 [Abstract] [Full Text] [Related]